NASDAQ:ADTX - Nasdaq - US0070258027 - Common Stock - Currency: USD
Taking everything into account, ADTX scores 1 out of 10 in our fundamental rating. ADTX was compared to 556 industry peers in the Biotechnology industry. Both the profitability and financial health of ADTX have multiple concerns. ADTX has a expensive valuation and it also scores bad on growth.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -100.36% | ||
ROE | -188.88% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.18 | ||
Debt/FCF | N/A | ||
Altman-Z | -10.53 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.08 | ||
Quick Ratio | 0.08 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
1.16
-0.05 (-4.13%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 50.88 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 0.17 | ||
P/tB | 0.17 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -100.36% | ||
ROE | -188.88% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.18 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 0.08 | ||
Quick Ratio | 0.08 | ||
Altman-Z | -10.53 |